Hemp (Cannabis sativa L.) Protein Hydrolysates Promote Anti-Inflammatory Response in Primary Human Monocytes
1Department of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, Universidad de Sevilla, 41009 Seville, Spain; noe91rm@gmail.com (N.M.R.-M.); delapaz@us.es (S.M.-d.l.P.); mtoscanos@us.es (R.T.); elenagraoc@gmail.com (E.G.-C.)
2Department of Food & Health, Instituto de la Grasa, CSIC, 41013 Seville, Spain; alvarovillanueva@ig.csic.es (A.V.); jjavier@cica.es (J.P.); fmillanr@ig.csic.es (F.M.)
3Cell Biology Unit, Instituto de la Grasa, CSIC, 41013 Seville, Spain
*Correspondence: mcmillan@ig.csic.es; Tel.: +34-954-61-15-50Abstract
Hemp seeds have a wide variety of chemical compounds which present biological activity. Specifically, the focus on proteins and bioactive peptides are increasing as alternative sources of nutraceutical uses. In the literature, hemp protein products (HPPs) have reported antioxidant and anti-inflammatory properties. This study aimed to determine the inflammation-related modulatory effects of HPPs on lipopolysaccharide (LPS)-activated primary human monocytes. CD14+ cells were immunomagnetically isolated from buffy coats and the anti-inflammatory activity of hemp protein isolate (HPI) and hydrolysates (HPHs) was evaluated on LPS-stimulated human primary monocytes. The specific markers of inflammation, polarization, and chemoattraction were measured by RT-qPCR and ELISA assays. Our results showed that HPPs decreased the pro-inflammatory mediators (TNF-α, IL-1β, and IL-6) and increased the anti-inflammatory mediators (IL-10 and IL-4). In addition, M1 polarization marker gene expression (CCR7 and iNOS) was downregulated by HPPs and, M2 polarization marker gene expression (CD200R and MRC1) was upregulated. Finally, the mRNA expression of chemotaxis genes (CCR2 and CCL2) was downregulated by HPPs. In conclusion, this study suggests that HPPs may improve chronic inflammatory states and promote regenerative processes by reprogramming monocytes toward M2 polarization phenotype.
1. Introduction
Cannabis sativa L. has been widely grown for several millennia [1]. Industrially, the plant is used for a stem fiber (also called hemp) and an edible oil derived from seeds. Plant varieties utilized for fiber and oilseed usually are low in the euphoria-inducing chemical named Δ9-tetrahydrocannabinol (THC) compared to drug varieties [2,3]. Hemp crop is legal since 1993 in many European countries. The cultivation area is even expanding, from 8000 ha in 2011 to reach more than 33,000 ha in 2016. The main reason for this crop to be enhanced is the environmental benefits; hemp is a valuable crop for less work time, lower costs, and greater profit, which improve the bio-based economy [4]. In addition, the Grand View Research (2020) reported that the economy of hemp crop will be increased, with at least USD 15 billion in 2027 [5]., due to hemp being the source of 25,000 biodegradable products which have increasing uses [4]. In recent years, hemp crop is increasing not only for industrial uses, but also for its health benefits. Due to multiple phytochemical compounds hemp seeds have also reached a greater degree of international scientific attention [6,7,8]. In particular, protein represents around 25% of the total hemp seed composition [9]. The major fraction of the total seed protein consists of storage proteins as globulins (65–75%), albumins (25–37%), and sulfur-rich proteins [10]. The most significant protein in hemp seed is edestin, a globulin rich in arginine and a recognized precursor of nitric oxide, which makes hemp seed protein of high interest to enhance cardiovascular health [10]. Nevertheless, the poor water solubility of hemp proteins are an obstacle for their use, which was technologically overwhelmed by enzymatic hydrolysis [11]. Hemp protein hydrolysates (HPHs) generated by enzymatic hydrolysis are composed of polypeptides, oligopeptides, and free amino acids displaying high availability of biological activity [8]. In the literature, HPHs have showed different biological activities as antihypertensive, hypocholesterolemic, antioxidant, antithrombotic, and immunomodulatory effects [8,9,11,12,13,14,15]. In addition, neuroprotective HPHs have been recently described in preliminary studies by our research team in a microglial BV2 cell line stimulated with lipopolysaccharide (LPS) [9]. However, HPHs’ effects have not yet been investigated in primary human blood circulating cells.
Peripheral blood mononuclear cells (PBMCs) are particularly linked to systemic inflammation and several diseases [16,17,18,19]. PBMCs include lymphoid cells as lymphocytes (T cells, B cells, and NK cells) and myeloid cells as monocytes. Monocytes are mononuclear cells that develop in the bone marrow and diffuse inside of the bloodstream. Monocytes have a plastic nature, which are capable of a notable range of phenotypic and functional changes which are conditioned by signals from local microenvironments [20,21]. In humans, monocytes are classified into three defined subsets: classical monocytes (CD14++CD16−), intermediate monocytes (CD14++CD16+), and non-classical monocytes (CD14+CD16++) [22]. As described previously, the polarization of macrophage-like cells from monocyte is classified into classically (M1) and alternatively (M2) activated groups [23]. Classical monocytes-derived M1 macrophages provoke the production of inflammatory cytokines and reactive nitrogen or oxygen reactive species that contribute to host defense, whereas non-classical monocytes-derived M2 macrophages attenuate inflammation and participate in tissue renovation. Regarding the current research, we further investigated whether hemp protein products (HPPs) may act as an immune-modulator and anti-inflammatory effector on human primary monocytes.
2. Materials and Methods
2.1. Chemical Compounds and Sampling
Seeds of Cannabis sativa L. were purchased from Sensi Seeds Bank. Alcalase 2.4 L (2.4 AU/g) and flavourzyme (1000 L) were a gift from Novozymes (Bagsvaerd, Denmark). Ficoll Histopaque and LPS (E. coli 055: B5) were provided by Sigma-Aldrich Chemistry. TRIsure (Bioline, Meridian Life Science, Inc. Memphis, TN, USA) and cDNA synthesis kits from Bio-rad (Berkeley, CA, USA) were used for RNA isolation. Quantitative PCR was performed by iTaq™ Universal SYBR® Green Supermix from Bio-rad. Primers were provided by Eurofins Biolab S.L.U (Barcelona, Spain). All reagents and solvents were of analytical grade and provided by Sigma Chemical Co. (St. Louis, MO, USA), Bachem AG (Bubendorf, Switzerland), and Gibco (Paisley, UK).
2.2. Hemp Protein Products Preparation
HPPs, that include hemp protein isolate (HPI) and hydrolysates (HPHs), were extendedly explained in preliminary studies as well as their chemical characterization [9]. Briefly, to obtain the HPI, the first step was defatting with n-hexane in a soxhlet, then was performed a first solubilization in alkali at pH 10.5 for 1 h, and, finally, the protein isolate was obtained by precipitation at the isoelectric point (pH 4.3). Second, the HPI was treated with proteases as alcalase or llavourzyme to obtain the different HPHs in a bioreactor under controlled conditions. In line with our previous results, HPI and HPHs with better ex-vivo antioxidant properties and in-vitro anti-neuroinflammatory potential, HPH20A and HPH60A15F, were used in this study. The HPH20A was obtained from HPI hydrolyzed during 20 min with alcalase; and HPH60A15F, was obtained from HPI hydrolyzed during 60 min with alcalase and an additional 15 min with alcalase+flavourzyme. These hydrolysates were boiled at 85 °C for 15 min to stop the enzymatic reaction. Finally, the supernatant was centrifugated (7500 rpm, 15 min) to obtain the HPHs. The resulting hydrolysates were composed of a mixture of amino acids and small peptides with biological activity. As an example, the HPHs were rich in negatively charged amino acids like asparagine and aspartic acid, and glutamine and glutamic acid, and also rich in arginine [9]. The chemical composition and amino acid characterization of hemp seed and HPPs are shown in the Appendix A (Table A1 and Table A2).
2.3. Blood Collection and Monocyte Isolation
To carry out this study, we used the Good Clinical Practice Guidelines procedure with the principles outlined in the Helsinki Declaration of the World Medical Association [24]. Peripheral blood mononuclear blood cells (PBMCs) were centrifugated over a Ficoll–Histopaque gradient isolated from buffy coat. Blood was donated by the Regional Blood Transfusion Center (Seville, Spain. Agreement #33130099). The donors were male, 25–35 years, declared themselves as non-smokers, and they were not taking any medication. Monocytes were isolated from PBMCs using CD14 MicroBeads (MACS, Myltenyi). Flow cytometry (FACScanto II flow cytometer and FACSDiva software, BD) showed a purity of the CD14 monocytes isolations > 95%, routinely. Following isolation, monocytes were maintained at Roswell Park Memorial Institute (RPMI) in 1640 medium enriched with L-glutamine, 10% heat-inactivated foetal bovine serum, and 1% penicillin/streptomycin in 5% CO2 at 37 °C in a CO2 incubator (Thermo Con Electron Corporation, Waltham, MA, USA).
2.4. Treatments of Cells in Culture
After isolation, monocytes (5 × 105 cells/well) were incubated with LPS (100 ng/mL) followed or not by 24 h treatment in 24-well plates with HPI, HPH20A, and HPH60A15F at 50 and 100 µg/mL. At the end of exposure time, supernatants were extracted and stored at −20 °C, and RNA was obtained using these cells.
2.5. Measurement of Cytokine Release
The supernatant was obtained in order to quantify the cytokine levels of TNF-α, IL-1β, IL-6, and IL-10 by the enzyme-linked immunosorbent assay (ELISA), using the instructions of the manufacturer protocol (Diaclone, Besancon, France). The amount of cytokine was calculated from calibration standard curves and expressed in pg per mL.
2.6. RNA Isolation and RT-qPCR Analysis
RNA from monocytes was isolated to quantify gene expression by RT-qPCR. Total RNA was obtained by using TRIsure Reagent. RNA quality was evaluated by A260/A280 ratio in a NanoDrop ND-1000 Spectrophotometer (ThermoFisher Scientific, Madrid, Spain). After that, the RNA was subjected to reverse transcription. The resulting cDNA was used in an amount of 10 g for RT-qPCR amplifications. A CFX96 system (Bio-Rad) was used to determine the mRNA levels for genes indicated below. For each PCR reaction, the Brilliant SYBR green QPCR Supermix containing the primer pairs for either gene, or for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and hypoxanthine phosphoribosyltransferase (HPRT) as housekeeping genes, was added to cDNA template. All PCR amplifications were accomplished in three identical copies and average threshold cycle (Ct) numbers of the triplicates were used to determine the relative mRNA expression of selected genes. The magnitude of change of mRNA expression for selected genes was assessed by using the 2−(ΔΔCt) mathematical method. All data were normalized to housekeeping gene constituents and expressed as relative fold-change of control. The designed oligonucleotides sequences are shown in Table 1.
2.7. Statistical Method
All values are expressed as arithmetic means ± standard deviations (SD). The output values were evaluated with Graph Pad Prism Version 5.01 software (San Diego, CA, USA). The one-way analysis of variance (ANOVA) was used to evaluate statistical significance of any difference in each parameter among the groups, following Tukey multiple comparisons test as post hoc tests. p values considered statistically significant were less than 0.05.
3. Results
3.1. Anti-Inflammatory Properties of Hemp Protein Hydrolysates
Chronic inflammation is key in several disorders [16,17,18,25,26,27,28,29,30,31] and the activation of circulating monocytes is a recognized process during inflammation [18,19]. Therefore, to assess the anti-inflammatory effect of HPHs, gene expression of TNF-α, IL-1β, IL-6, IL-10, and IL-4 was measured by RT-qPCR in LPS-stimulated primary human monocytes. As shown in Figure 1A–C, the inflammation induced by LPS upregulates the mRNA levels of TNF-α, IL-1β, and IL-6 compared to those in untreated cells. However, this inflammatory state is blocked with the presence of HPI, HPH20A, and HPH60A15F at 50 or 100 µg/mL. In addition, the mRNA levels of the anti-inflammatory cytokines IL-10 (Figure 1D) and IL-4 (Figure 1E) are upregulated with the presence of HPH60A15F at 50 or 100 µg/mL. However, the treatment with HPI and HPH20A does not show an upregulation of these anti-inflammatory genes compared to HPH60A15F. At higher concentration, HPI slightly upregulates IL-10, meanwhile HPI and HPH20A slightly upregulate IL4 in LPS-stimulated primary human monocytes. This capacity of HPPs to decrease the transcriptional activity of pro-inflammatory genes and to increase the transcriptional activity of anti-inflammatory genes, is also linked with a reduced release of TNF-α (Figure 2A), IL-1β (Figure 2B), and IL-6 (Figure 2C) cytokines and an increased release of IL-10 (Figure 2D) into cell culture supernatant.
3.2. Hemp Protein Hydrolysates Shifts M1 toward M2 Macrophage Phenotype
The cytokine microenvironment of monocytes may define the polarization state toward M1 or M2 macrophage phenotypes. The cytokines associated to M1 phenotype are pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. Hence, the current classification between M1 and M2 macrophages gives emphasis to the expression of other genes which are related to their functional properties [21,23]. Gene expression of phenotypic markers for M1, such as CCR7 and iNOS, and phenotypic markers for M2, such as CD200R and MRC1, was investigated. As shown in Figure 3A,B, the transcriptional mRNA levels of CCR7 and iNOS are upregulated with LPS. However, HPHs downregulate the transcriptional mRNA levels of M1 polarization marker genes. In contrast, HPHs particularly promote CD200R (Figure 3C) and MRC1 (Figure 3D) transcriptional activity. These results may indicate that HPPs, particularly HPH60A15F, shift macrophage polarization from M1 toward M2.
3.3. Hemp Protein Hydrolysates Modulates CCR2-Dependent Migration
In gaining deeper insight into the role of HPPs on human monocyte plasticity, we studied the modulation of the CCR2/CCL2 axis. Classically activated or M1 macrophages are recruited into the inflamed tissue via the CCR2 signaling pathway, which regulates the monocyte migration. Conversely, the alternatively activated or M2 macrophages are characterized for their poor migratory ability [21,23]. In establishing the physiological relevance of this pathway, the mRNA expression of CCR2 and CCL2 genes in the presence of hemp protein products was analyzed by RT-qPCR (Figure 4). The mRNA levels of CCR2 (Figure 4A) and CCL2 (Figure 4B) are upregulated with LPS compared to those in untreated cells. The transcriptional activity of CCR2 and CCL2 are downregulated in the presence of HPHs but not in the presence of HPI. Notably, HPH60A15F significantly downregulates mRNA levels compared to HPH20A. These results might confirm that HPHs polarize primary human monocytes toward M2 poorly migratory anti-inflammatory macrophages.
4. Discussion
Current dietary habits are driven towards the consumption of ready-to-eat foods rich in refined sugars and unhealthy fats. Nutritional interventions have been consistently proposed as a part of a comprehensive strategy to lower the incidence and severity of several diseases. Excessive consumption of animal-based proteins is associated with an increased risk of atherosclerosis and cancer [29,30,31]. By contrast, replacement of animal- with plant-based proteins has been reported to be inversely associated with risk of atherosclerosis [30]. The industrial hempseed, i.e., the non-drug cultivars of C. sativa, is undoubtedly an underexploited protein-rich seed [32]. Hempseed proteins are an excellent natural source of digestible amino acids in comparison to other protein sources, such as borage meal, canola meal, and heated canola meal [33,34]. The literature evidence shows that the most effective HPPs identified so far are ACE-inhibitory peptides, which are composed of 2–20 amino acids. In addition, they should present good chemical properties such as the balance of hydrophobicity/hydrophilicity and some particular structural characteristics related to its sequence [13,32,35,36]. In previous results of our research team, we evaluated the potential antioxidant activity of the HPIs, HPHs with alcalase, and HPHs with alcalase and flavourzyme in cell-free in vitro and microglial BV2 experiments [9]. HPHs inhibited oxidative stress and inflammatory response in activated microglia, however, the immunomodulatory effects of HPHs have not yet been investigated in primary human monocytes.
Monocytes are determinative cells in the development and propagation of the inflammatory nature and atherosclerosis onset. The normal activity of primary human monocytes is known to be substantially disturbed by activation during the plaque formation [24,25]. Activation of monocytes is observed in chronic inflammatory processes, i.e., cardiovascular diseases. When monocytes are exposed to LPS, they produce several inflammatory mediators which are involved in different injuries and diseases, particularly in inflammation, metabolic, and vascular-related disorders [17,18,19]. During inflammation, the dual roles of monocytes are defined in part by two specific morphological phenotypes of macrophages that they have the tendency to be polarized into. The M1 macrophages stem from classical monocytes, which are rich in CD14 and show high expression of chemotaxis genes such as CCR2 (C-C chemokine receptor 2) and CCL2 (C-C ligand 2, also referred to as monocyte chemoattractant protein 1) [18,22]. On the other hand, the M2 macrophages stem from non-classical monocytes, which are rich in CD16 and show high expression of CD200R (Cell surface glycoprotein CD200 receptor) and MRC1 (C-type mannose receptor 1) [21,23]. The M1 phenotype is a pro-inflammatory state and is involved in the production of inflammatory mediators, including pro-inflammatory cytokines (IL-1β, TNF-α, and IL-6) and chemokines, and induces oxidative stress damage by iNOS (inducible nitric oxide synthase) induction. Alternatively, the M2 phenotype is involved in the production of protective cytokines (IL-4 and IL-10) and plays an important role in tissue repairs [21].
Given the importance of monocytes on innate immune function, our study highlights the effects of HPPs on the inflammatory response in LPS-activated primary human monocytes. In the literature, it is possible to find a representative number of cases where plant-derived biopeptides are used as anti-inflammatory or antioxidant chemicals. A model of them is 1,2,3,4,6 penta-O-galloyl-β-D-glucose, a naturally occurring polyphenolic chemical present in some therapeutical herbs as Rhuschinensis Mill [37]. One more example of a bioactive plant is Fagopyrum tataricum, widely named as buckwheat. Other isolated chemicals with anti-inflammatory activity in activated PBMCs (monocytes or macrophages) are the Brazilian red propolis (Apis mellifera), Copaifera oleoresins, Citrus bergamia juice flavonoid fraction, effusanin C (Isodon japonicus), and oligomeric proanthocyanidins (Crataegus oxyacantha) [38,39,40,41,42]. Lunasin, a 43-amino acid multifunctional bioactive peptide in soybean seeds, has been found to exert numerous biological activities, including anti-inflammatory and antioxidant properties, in human monocytic leukemia cell line THP-1 cells [43]. In addition, GPETAFLR, an octapeptide isolated from Lupinus angustifolius L., showed an anti-inflammatory effect in LPS-stimulated primary human monocytes [44]. In the present study HPHs have shown diminished inflammation in LPS-stimulated primary human monocytes. These observations are consistent with the mRNA levels of inflammatory cytokines, with additional contributions to the M2 phenotype polarization, as well as the CCR2-dependent migration markers. Hence, the activated macrophages treated with HPPs might target the inflammation and successfully prevent inflammatory states and inflammatory derived complications from several human diseases. This anti-inflammatory capacity may be a result of biopeptide presence or the synergistic association of free amino acids which exert primary antioxidant activity [8,9].
Our study is supplementary to a previous one in which HPPs were demonstrated to show an antioxidant ability in ex-vivo experiments as well as anti-inflammatory properties in murine BV-2 microglial cells [9]. However, the targeting pathways of the immune system by HPHs are unknown. Subsequent to these observations, the literature evidence have been suggested that the LPS-activated-macrophages promote pro-inflammatory pathways such as the nuclear factor (NF)-κB signaling pathway and the Janus-activated kinase (JAK)/STAT3-dependent pathway [17,29]. On this matter, some authors have observed that LPS is recognized by TLR4 (toll like receptor-4) in human monocytes [28,29]. This receptor could activate the NF-κB pathway. As a result, the activated pro-inflammatory pathways are involved in the release of iNOS. Our results showed that LPS-activated monocytes produce an increase in iNOS transcriptional levels, though the HPP treatments have induced a normalization of the iNOS transcriptional levels. In addition, other observations may drive the investigation to the nucleotide-binding domain and leucine-rich repeat containing protein (NLR) expression and the NLRP3 inflammasome activation pathway which regulate the secretion of IL-1β [20]. As was observed, IL-1β was increased in the LPS-activated monocytes, which may indicate NLRP3 inflammasome activation. At which time, further studies should be directed toward the targeting pro-inflammatory pathway in presence of HPHs.
5. Conclusions
Taken together, our outcomes suggest that both hydrolysates, HPH20A and HPH60A15F, have significant anti-inflammatory properties in LPS-activated primary human monocytes. Additionally, both hydrolysates have the capacity of regenerated inflammatory processes by an over-activation of M2 phagocytes, as is summarized in Figure 5. Therefore, the present study reveals new beneficial effects of hemp protein products, including HPH20A and HPH60A15F, as well as allows their potential uses in the prevention and treatment of inflammation-related conditions as natural bioactive compounds.
Acknowledgments
This work was supported by grant CYTED-2019 119RT0567 from the Spanish Ministry of Science, Innovation, and Universities. Authors thank Cell Biology Unit of Instituto de la Grasa for its assistance during the fulfilment of this work, and the University of Seville for financial support from “V Own Research Plan”.
Funding
This research was funded by CYTED Ciencia y Tecnología para el Desarrollo, grant number CYTED-2019 119RT0567.
Conflicts of Interest
All the authors declare no conflict of interest.
Appendix Group
Appendix A
| Nutrient (g/100 g Product) | Hemp Seed | Hemp Protein Isolate (HPI) | Hemp Protein Hydrolysate: HPH20A | Hemp Protein Hydrolysate: HPH 60A + 15AF |
|---|---|---|---|---|
| Proteins | 24.18 ± 1.01 | 96.46 ± 0.93 | 86.56 ± 0.78 | 83.02 ± 0.29 |
| Carbs | 3.81 ± 0.76 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| Fat | 32.35 ± 0.57 | --------- | --------- | --------- |
| Humidity | 4.49 ± 0.01 | 2.19 ± 0.01 | 7.34 ± 0.03 | 8.85 ± 0.04 |
| Ash | 5.09 ± 0.07 | 1.06 ± 0.10 | 6.10 ± 0.75 | 8.13 ± 0.26 |
| Fiber | 29.72 ± 1.44 | 00.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| Polifenols | 0.35 ± 0.02 | 0.04 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| Amino Acids (g/100 g Protein) | Defatted Hemp Flour (DHF) | Hemp Protein Isolate (HPI) | Hemp Protein Hydrolysate: HPH20A | Hemp Protein Hydrolysate: HPH 60A + 15AF |
|---|---|---|---|---|
| Aspartic acid + asparragine | 11.34 ± 0.37 | 12.35 ± 0.34 | 12.40 ± 0.29 | 12.08 ± 0.51 |
| Glutamic acid + Glutamine | 18.41 ± 0.13 | 18.86 ± 0.35 | 18.83 ± 0.25 | 18.58 ± 0.12 |
| Alanine | 4.89 ± 0.10 | 5.01 ± 0.14 | 4.99 ± 0.10 | 5.00 ± 0.11 |
| Arginine | 12.68 ± 0.21 | 13.44 ± 0.03 | 13.34 ± 0.24 | 13.78 ± 0.23 |
| Cysteine | 1.22 ± 0.02 | 1.98 ± 0.08 | 1.81 ± 0.18 | 1.65 ± 0.21 |
| Glycine | 4.74 ± 0.07 | 4.79 ± 0.23 | 4.64 ± 0.11 | 4.64 ± 0.12 |
| Histidine | 3.07 ± 0.01 | 2.85 ± 0.05 | 2.80 ± 0.02 | 2.79 ± 0.03 |
| Isoleucine | 4.23 ± 0.08 | 3.02 ± 0.40 | 3.57 ± 0.15 | 3.85 ± 0.20 |
| Leucine | 7.12 ± 0.05 | 7.13 ± 0.11 | 7.12 ± 0.13 | 7.34 ± 0.07 |
| Lysine | 3.78 ± 0.09 | 3.04 ± 0.08 | 3.10 ± 0.06 | 3.23 ± 0.04 |
| Methionine | 2.14 ± 0.02 | 0.89 ± 0.34 | 0.60 ± 0.03 | 0.64 ± 0.04 |
| Phenylalanine | 4.76 ± 0.09 | 5.12 ± 0.02 | 5.04 ± 0.05 | 5.19 ± 0.08 |
| Proline | 2.66 ± 0.69 | 3.02 ± 0.00 | 2.83 ± 0.05 | 1.29 ± 0.19 |
| Serine | 5.57 ± 0.11 | 6.31 ± 0.21 | 6.36 ± 0.19 | 6.31 ± 0.22 |
| Threonine | 3.79 ± 0.08 | 3.79 ± 0.10 | 3.89 ± 0.06 | 4.02 ± 0.07 |
| Tryptophan | 0.76 ± 0.05 | 0.55 ± 0.02 | 0.66 ± 0.01 | 0.82 ± 0.03 |
| Tyrosine | 3.57 ± 0.06 | 4.08 ± 0.06 | 3.98 ± 0.03 | 4.06 ± 0.12 |
| Valine | 5.27 ± 0.11 | 3.77 ± 0.40 | 4.05 ± 0.42 | 4.71 ± 0.19 |
| Target | GeneBank Accession Number | Forward Reverse | Sequence (5′ → 3′) |
|---|---|---|---|
| TNF-α | NM_000594 | Forward Reverse | TCCTTCAGACACCCTCAACC AGGCCCCAGTTTGAATTCTT |
| IL-1β | NM_000576 | Forward Reverse | GGGCCTCAAGGAAAAGAATC TTCTGCTTGAGAGGTGCTGA |
| IL-6 | NM_000600 | Forward Reverse | TACCCCCAGGAGAAGATTCC TTTTCTGCCAGTGCCTCTTT |
| IL-10 | NM_000572 | Forward Reverse | GCCTAACATGCTTCGAGATC TGATGTCTGGGTCTTGGTTC |
| IL-4 | NM_021283.2 | Forward Reverse | TCAACCCCCAGCTAGTTGTC TGTTCTTCGTTGCTGTGAGG |
| CCR7 | NM_007719.2 | Forward Reverse | GTGTGCTTCTGCCAAGATGA CCACGAAGCAGATGACAGAA |
| iNOS | NM_ 000625 | Forward Reverse | ACCCAGACTTACCCCTTTGG GCCTGGGGTCTAGGAGAGAC |
| CD200R | NM_138940.2 | Forward Reverse | GTTGCCCTCCTATCGCATTA TGGAAATTCCCATCAGGTGT |
| MRC1 | NM_ 138806 | Forward Reverse | GGCGGTGACCTCACAAGTAT ACGAAGCCATTTGGTAAACG |
| CCR2 | NM_001123396.1 | Forward Reverse | TGCCTGACTCACACTCAAGG GGCTTCTCAGCAACTGAACC |
| CCL2 | NM_002982.3 | Forward Reverse | CCCCAGTCACCTGCTGTTAT ACGAAGCCATTTGGTAAACG |
| HPRT | NM_001289746 | Forward Reverse | ACCCCACGAAGTGTTGGATA AAGCAGATGGCCACAGAACT |
| GADPH | NM_001289746 | Forward Reverse | CACATGGCCTCCAAGGAGTAAG CCAGCAGTGAGGGTCTCTCT |